InCELLia

InCELLia team was awarded as part of the EIC Pathfinder project ALLADIN to develop a platform to accelerate the discovery of therapeutic nanobodies for improved treatment of cancer

The InCELLia team attended the first Heidelberg Conference on Cancer Neuroscience between the 18th – 19th of 2023 and presented their posters on modeling perineural invasion and the effect of chronic stressand intercellular competition on lymphatics in the microenvironmental niche.

Read More

InCELLia is keen on forming worldwide partnerships across various scientific disciplines, such as the bio and health industry, and pharmaceuticals, and participating in competitive research initiatives.The goal is to attain noteworthy scientific outcomes and to create consumer products.

EIC Pathfinder Research Project: developing a platform to accelerate the discovery of therapeutic nanobodies for cancer (EIC Pathfinder program 2023 of the European Innovation Council (EIC) under Grant Agreement #101130574.)

Our team has established research collaborations with universities and research institutes, as well as with university hospitals at both national and international levels.